According to finsmes.com:
Datavant, a San Francisco, CA-based provider of solutions for life sciences and healthcare organizations to connect their data while protecting patient privacy, raised $40m in Series B funding.
The round, which brought Datavant’s cumulative fundraising to $83m, was led by Transformation Capital, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc. and Cigna Ventures, as well as participation by existing shareholders Roivant Sciences and Flex Capital.